Cost-Effectiveness Analysis of Abiraterone Acetate Treatment Compared with Cabacitaxel in the Republic of Panama, in Patients with Metastatic Castration-Resistant Prostate Cancer that Have Failed to Chemotherapy with Docetaxel
Nov 1, 2014, 00:00
10.1016/j.jval.2014.08.2261
https://www.valueinhealthjournal.com/article/S1098-3015(14)04191-6/fulltext
Title :
Cost-Effectiveness Analysis of Abiraterone Acetate Treatment Compared with Cabacitaxel in the Republic of Panama, in Patients with Metastatic Castration-Resistant Prostate Cancer that Have Failed to Chemotherapy with Docetaxel
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)04191-6&doi=10.1016/j.jval.2014.08.2261
First page :
A632
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
1723